OA05.01 Role of HLA-E antigen presentation on NK control of HIV infection Oral Abstract SessionInnate and trained immunity
OA03.02 Safety and PK of Potent Anti-HIV Monoclonal AB VRC07-523LS in HIV-exposed InfantsOral Abstract SessionBroadly neutralizing antibodies
OA03.01 Safety and single-dose pharmacokinetics of VRC07-523LS administered via different routes and dosesOral Abstract SessionClinical trial results
PE01.01 Screening for common mental disorders among anti-retroviral therapy (ART) users: Implications of case-finding for treatment of mental disorders, ART adherence and viral suppressionE-posterBehavioural and social science research
PU01.18 Self-reported sexual behavior and prostate specific antigen detection among women randomized to injectable depot-medroxyprogesterone-acetate, copper intrauterine device and levonorgestrel implant in the Evidence for Contraceptive Options and HIV OutcomesPublication OnlyBehavioural and social science research
OA01.04 Serum IgA inhibits HIV-specific broadly neutralising antibody Fc functionsOral Abstract SessionBroadly neutralizing antibodies
PE01.41 Service providers perception of a home-based intervention to test and start (HITS) in rural KwaZulu-Natal, South AfricaE-posterBehavioural and social science research
PE07.04 Sex work in the wake of SARSCoV2 in Zimbabwe: A qualitative studyE-posterCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PE16.40LB Sexual behavior and sexually transmitted infections are increased after PrEP initation: results from a longitudial study among MSM who initiated PrEP during follow-upE-posterImplementation science, including structural interventions, PrEP & VMMC
PE11.09 Sexual behavior associated with circumcision status among males aged 15-49 in Zambia and Eswatini: evidence of risk compensation?E-posterEpidemiology of HIV
seek-warrow-warrow-eseek-e341 - 350 of 444 items